Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis.

Rodriguez, Alfredo E

Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis. [electronic resource] - Current pharmaceutical design 2018 - 465-477 p. digital

Publication Type: Journal Article; Meta-Analysis; Review

1873-4286

10.2174/1381612824666180108121834 doi


Acute Coronary Syndrome--drug therapy
Clopidogrel--adverse effects
Humans
Observational Studies as Topic
Percutaneous Coronary Intervention
Prasugrel Hydrochloride--therapeutic use
Randomized Controlled Trials as Topic
Registries
Ticagrelor--therapeutic use